Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK novel HPV vaccine long-term follow-up
NCT00359619Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of HPV-16/18/31/45 L1 AS04 Formulation 3 in human papillomavirus infection, Cervical Cancer (CC), sponsored by GSK. Started Sep 2006; status: completed.
02
Drugs
HPV-16/18/31/45 L1 AS04 Formulation 3
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on NCT00359619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359619.